The Medibank (ASX:MPL) share price is up 18% so far in 2021. Here's why

Here's what's driven the Medibank share price this year.

| More on:
ASX share price movement represented by doctor pressing digitised screen with array of icons including one entitled health insurance,

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medibank Private Ltd (ASX: MPL) share price has been having a great year so far on the ASX.

Perhaps more impressive, the health insurance and solutions company's gains have come despite it only releasing news a handful of times.

Right now, the Medibank shares are trading for $3.54 apiece, 17.28% higher than they were at the start of 2021.

Let's take a closer look at what the S&P/ASX 200 Index (ASX: XJO) company has been up to in 2021.

What's driven the Medibank share price in 2021?

It's been a good year for Medibank shares, despite the company keeping relatively quiet. Here's what we've heard from Medibank in 2021.

Myhealth acquisition

In early February, Medibank announced it had acquired a non-controlling 33.4% interest in Myhealth Medical Group.

Myhealth operates 86 primary care clinics scattered across Victoria, New South Wales, and Queensland.

According to Medibank, the investment strengthened its focus on preventive health and doctor-led partnerships.

The Medibank share price didn't react to the news.

Half yearly results

A matter of weeks later, Medibank released its results for the first half of financial year 2021.

For the 6 months ended 31 December 2020, Medibank recorded net profits after tax of $226.4 million, a 27.3% increase on those of the prior corresponding period.

It also reported that its income from premiums rose 0.3% to $3.3 billion, while its net claims expenses dropped $24.1 million – or 0.8%.

Medibank also announced a 5.8 cent fully franked dividend.

Finally, the company announced its CEO, Craig Drummond, was to retire. Medibank's new CEO David Koczkar took over the role on 17 May.

The Medibank share price fell 3.4% on the back of the results.

Returning money to customers

Lastly, in April Medibank announced that it plans to return around $105 million it's saved during COVID-19 to its customers.

According to Medibank, the savings came from its customers deferring their claims due to the global pandemic.

The Medibank share price fell 0.6% the day the company announced the give-back.

Medibank share price snapshot

After starting 2021 at $3.04, the Medibank share price is now $3.54.

It has also gained 24% since this time last year.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Up 43% since December, ASX 300 healthcare share announces milestone achievement

The ASX healthcare stock is working across 140 clinical sites.

Read more »

Beautiful young woman drinking fresh orange juice in kitchen.
Healthcare Shares

Two booming ASX healthcare stocks investors should be buying the dip on

Is this a buy the dip opportunity?

Read more »

Scientist looking at a laptop thinking about the share price performance.
Healthcare Shares

Why this beaten down ASX 200 healthcare stock could rebound 66%

Bell Potter sees potential for this healthcare stock to deliver big returns from current levels.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Healthcare Shares

Ahead of its earnings results, Macquarie reckons this healthcare company is severely undervalued

A surprise on the upside is a definite possibility.

Read more »

Buy, hold, and sell ratings written on signs on a wooden pole.
Healthcare Shares

3 reasons to buy CSL shares today

A leading investment expert forecasts a stronger year ahead for CSL shares. Let’s see why.

Read more »

A man pulls a shocked expression with mouth wide open as he holds up his laptop.
Healthcare Shares

ASX 200 healthcare stock sinks 9% on FDA update

Let's see what this stock has announced on Thursday.

Read more »

Man with a sleep apnoea mask on whilst sleeping.
Healthcare Shares

3 reasons to buy this heavyweight ASX healthcare share

This one is for investors seeking quality, global reach, and durable earnings.

Read more »

A corporate man crosses his arms to make an X, indicating no deal.
Healthcare Shares

1 reason I'm never selling CSL shares

It might be tempting to offload this one but I think that would be the wrong move.

Read more »